APA (7th ed.) Citation

S, L., M, L., E, L. P., L, M., & E, L. (2022). Trends in disease-modifying therapy use in patients with multiple sclerosis using a 10-year population-based cohort study in France. Expert review of neurotherapeutics, 22(5), 411. https://doi.org/10.1080/14737175.2022.2061950

Chicago Style (17th ed.) Citation

S, Leblanc, Lefort M, Le Page E, Michel L, and Leray E. "Trends in Disease-modifying Therapy Use in Patients with Multiple Sclerosis Using a 10-year Population-based Cohort Study in France." Expert Review of Neurotherapeutics 22, no. 5 (2022): 411. https://doi.org/10.1080/14737175.2022.2061950.

MLA (9th ed.) Citation

S, Leblanc, et al. "Trends in Disease-modifying Therapy Use in Patients with Multiple Sclerosis Using a 10-year Population-based Cohort Study in France." Expert Review of Neurotherapeutics, vol. 22, no. 5, 2022, p. 411, https://doi.org/10.1080/14737175.2022.2061950.

Warning: These citations may not always be 100% accurate.